Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ryan

Showing results (891-900 of 989) with videos related to

Pageof 99
Sort By:
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Human Brain Mapping|November 29, 2017
Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studiesPeter Kochunov, Erin W Dickie, Joseph D Viviano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor modelsGina Song, David B Darr, Charlene M Santos, et al.
Circulation. Genomic and Precision Medicine|February 21, 2023
Multi-Omic Architecture of Obstructive Hypertrophic CardiomyopathyRamin Garmany, J Martijn Bos, David J Tester, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Journal of Gastroenterology and Hepatology|February 18, 2024
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapyN M Batt, B Rodrigues, S Bloom, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.
Pageof 99

Showing results (891-900 of 989) with videos related to

Sort By:
Pageof 99
Cancer Chemotherapy and Pharmacology|September 4, 2014
A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasmsWilliam D Figg, Manish Monga, Donna Headlee, et al.
Human Brain Mapping|November 29, 2017
Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studiesPeter Kochunov, Erin W Dickie, Joseph D Viviano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor modelsGina Song, David B Darr, Charlene M Santos, et al.
Circulation. Genomic and Precision Medicine|February 21, 2023
Multi-Omic Architecture of Obstructive Hypertrophic CardiomyopathyRamin Garmany, J Martijn Bos, David J Tester, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Journal of Gastroenterology and Hepatology|February 18, 2024
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapyN M Batt, B Rodrigues, S Bloom, et al.
Cancer Cell|June 16, 2012
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanomaWenjin Liu, Kimberly B Monahan, Adam D Pfefferle, et al.
The Journal of Clinical Investigation|April 9, 2013
HIF1α and HIF2α independently activate SRC to promote melanoma metastasesSara C Hanna, Bhavani Krishnan, Sean T Bailey, et al.
Neuro-Oncology|June 13, 2017
MerTK as a therapeutic target in glioblastomaJing Wu, Lauren N Frady, Ryan E Bash, et al.
Pageof 99